PAM
ITCI
Premier Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,119
| Closed | -$377K | – | 163 |
|
|
2021
Q3 | $377K | Sell |
10,119
-32,492
| -76% | -$1.21M | 0.05% | 127 |
|
|
2021
Q2 | $1.74M | Buy |
42,611
+30,152
| +242% | +$1.23M | 0.26% | 64 |
|
|
2021
Q1 | $423K | Sell |
12,459
-14,147
| -53% | -$480K | 0.08% | 137 |
|
|
2020
Q4 | $846K | Sell |
26,606
-1,131
| -4% | -$36K | 0.17% | 82 |
|
|
2020
Q3 | $712K | Buy |
27,737
+7,023
| +34% | +$180K | 0.18% | 70 |
|
|
2020
Q2 | $532K | Sell |
20,714
-10,840
| -34% | -$278K | 0.18% | 71 |
|
|
2020
Q1 | $485K | Buy |
+31,554
| New | +$485K | 0.2% | 70 |
|
|
2019
Q3 | – | Sell |
-72,758
| Closed | -$944K | – | 149 |
|
|
2019
Q2 | $944K | Buy |
+72,758
| New | +$944K | 0.22% | 66 |
|
|
2019
Q1 | – | Sell |
-63,304
| Closed | -$721K | – | 147 |
|
|
2018
Q4 | $721K | Buy |
+63,304
| New | +$721K | 0.19% | 78 |
|
|
2018
Q2 | – | Sell |
-19,088
| Closed | -$402K | – | 133 |
|
|
2018
Q1 | $402K | Buy |
19,088
+2,262
| +13% | +$47.6K | 0.09% | 97 |
|
|
2017
Q4 | $244K | Sell |
16,826
-1,603
| -9% | -$23.2K | 0.05% | 115 |
|
|
2017
Q3 | $291K | Buy |
+18,429
| New | +$291K | 0.07% | 105 |
|